ADAR1 Capital Management’s Pliant Therapeutics PLRX Stock Holding History

ADAR1 Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.28M	Buy	5,509,724 +2,924,598	+113%	+$3.56M	0.29%	80
2026 Q1	$3.26M	Buy	2,585,126 +2,511,307	+3,402%	+$3.17M	0.19%	102
2025 Q4	$90.1K	Buy	+73,819	New	+$111K	0.01%	256
2025 Q3	–	Sell	-82,189	Closed	-$95.3K	–	250
2025 Q2	$95.3K	Buy	+82,189	New	+$116K	0.01%	179
2025 Q1	–	Sell	-134,798	Closed	-$1.78M	–	239
2024 Q4	$1.78M	Sell	134,798 -111,330	-45%	-$1.52M	0.35%	53
2024 Q3	$2.76M	Buy	246,128 +236,128	+2,361%	+$2.95M	0.45%	42
2024 Q2	$108K	Buy	+10,000	New	+$129K	0.02%	163

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

ADAR1 Capital Management's PLRX Position: Q2 2026 in Review

ADAR1 Capital Management increased its Pliant Therapeutics (PLRX) stake by 113% in Q2 2026, buying an estimated $3.56M and bringing the position to 5,509,724 shares worth $6.28M. The position accounts for 0.29% of the portfolio, ranked #80.

ADAR1 Capital Management first reported a position in PLRX in Q2 2024 and has held it in 7 quarters since. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

ADAR1 Capital Management held 5,509,724 shares of Pliant Therapeutics worth $6.28M as of Q2 2026.
ADAR1 Capital Management bought 2,924,598 Pliant Therapeutics shares in Q2 2026, an estimated $3.56M.
Pliant Therapeutics made up 0.29% of ADAR1 Capital Management's portfolio in Q2 2026, its #80 holding.
ADAR1 Capital Management first reported a position in Pliant Therapeutics in Q2 2024 and has held it in 7 quarters since.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.